These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 30146732)

  • 1. Canine intranasal tumours treated with alternating carboplatin and doxorubin in conjunction with oral piroxicam: 29 cases.
    Woodruff MJ; Heading KL; Bennett P
    Vet Comp Oncol; 2019 Mar; 17(1):42-48. PubMed ID: 30146732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of eight dogs with nasal tumours with alternating doses of doxorubicin and carboplatin in conjunction with oral piroxicam.
    Langova V; Mutsaers AJ; Phillips B; Straw R
    Aust Vet J; 2004 Nov; 82(11):676-80. PubMed ID: 15977611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of toxicities from combined metronomic and maximal-tolerated dose chemotherapy in dogs with osteosarcoma.
    Bracha S; Walshaw R; Danton T; Holland S; Ruaux C; Obradovich J
    J Small Anim Pract; 2014 Jul; 55(7):369-74. PubMed ID: 24803081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized phase III trial of piroxicam in combination with mitoxantrone or carboplatin for first-line treatment of urogenital tract transitional cell carcinoma in dogs.
    Allstadt SD; Rodriguez CO; Boostrom B; Rebhun RB; Skorupski KA
    J Vet Intern Med; 2015 Jan; 29(1):261-7. PubMed ID: 25619518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary frontal sinus squamous cell carcinoma in three dogs treated with piroxicam combined with carboplatin or toceranib.
    de Vos J; Ramos Vega S; Noorman E; de Vos P
    Vet Comp Oncol; 2012 Sep; 10(3):206-13. PubMed ID: 22236048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combined palliative hypofractionated radiation and carboplatin chemotherapy of intranasal tumours in dogs].
    Schwietzer A; Kessler M; Kandel-Tschiederer B
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2012 Oct; 40(5):333-40. PubMed ID: 23076017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carboplatin versus alternating carboplatin and doxorubicin for the adjuvant treatment of canine appendicular osteosarcoma: a randomized, phase III trial.
    Skorupski KA; Uhl JM; Szivek A; Allstadt Frazier SD; Rebhun RB; Rodriguez CO
    Vet Comp Oncol; 2016 Mar; 14(1):81-7. PubMed ID: 24118677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival times for canine intranasal sarcomas treated with radiation therapy: 86 cases (1996-2011).
    Sones E; Smith A; Schleis S; Brawner W; Almond G; Taylor K; Haney S; Wypij J; Keyerleber M; Arthur J; Hamilton T; Lawrence J; Gieger T; Sellon R; Wright Z
    Vet Radiol Ultrasound; 2013; 54(2):194-201. PubMed ID: 23278974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety evaluation of combination carboplatin and toceranib phosphate (Palladia) in tumour-bearing dogs: A phase I dose finding study.
    Wouda RM; Hocker SE; Higginbotham ML
    Vet Comp Oncol; 2018 Mar; 16(1):E52-E60. PubMed ID: 28799187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant melanoma in 63 dogs (2001-2011): the effect of carboplatin chemotherapy on survival.
    Brockley LK; Cooper MA; Bennett PF
    N Z Vet J; 2013 Jan; 61(1):25-31. PubMed ID: 22913610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and toxicity of combined oclacitinib and carboplatin or doxorubicin in dogs with solid tumors: a pilot study.
    Barrett LE; Gardner HL; Barber LG; Sadowski A; London CA
    BMC Vet Res; 2019 Aug; 15(1):291. PubMed ID: 31409327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective evaluation of doxorubicin-piroxicam combination for the treatment of transitional cell carcinoma in dogs.
    Robat C; Burton J; Thamm D; Vail D
    J Small Anim Pract; 2013 Feb; 54(2):67-74. PubMed ID: 23286739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carboplatin and doxorubicin combination chemotherapy for the treatment of appendicular osteosarcoma in the dog.
    Bailey D; Erb H; Williams L; Ruslander D; Hauck M
    J Vet Intern Med; 2003; 17(2):199-205. PubMed ID: 12683621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent 5-fluorouracil and carboplatin for the treatment of canine carcinomas.
    Menard K; Flesner BK; Glahn A; Boudreaux B; Bryan JN
    Vet Comp Oncol; 2018 Dec; 16(4):590-595. PubMed ID: 30043425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of carboplatin and doxorubicin-based chemotherapy protocols in 470 dogs after amputation for treatment of appendicular osteosarcoma.
    Selmic LE; Burton JH; Thamm DH; Withrow SJ; Lana SE
    J Vet Intern Med; 2014; 28(2):554-63. PubMed ID: 24512451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of carboplatin in multi-modality treatment of canine tonsillar squamous cell carcinoma--a case series of five dogs.
    Murphy S; Hayes A; Adams V; Maglennon G; Neath P; Ladlow J; Brearley MJ
    J Small Anim Pract; 2006 Apr; 47(4):216-20. PubMed ID: 16573766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OUTCOME OF DOGS WITH INTRANASAL LYMPHOMA TREATED WITH VARIOUS RADIATION AND CHEMOTHERAPY PROTOCOLS: 24 CASES.
    George R; Smith A; Schleis S; Brawner W; Almond G; Kent M; Wypij J; Borrego J; Moore A; Keyerleber M; Kraiza S
    Vet Radiol Ultrasound; 2016 May; 57(3):306-12. PubMed ID: 26763938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Piroxicam, mitoxantrone, and coarse fraction radiotherapy for the treatment of transitional cell carcinoma of the bladder in 10 dogs: a pilot study.
    Poirier VJ; Forrest LJ; Adams WM; Vail DM
    J Am Anim Hosp Assoc; 2004; 40(2):131-6. PubMed ID: 15007049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a combination chemotherapy protocol including lomustine and doxorubicin in canine histiocytic sarcoma.
    Cannon C; Borgatti A; Henson M; Husbands B
    J Small Anim Pract; 2015 Jul; 56(7):425-9. PubMed ID: 25828786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Toceranib/Piroxicam/Cyclophosphamide Maintenance Therapy on Outcome of Dogs with Appendicular Osteosarcoma following Amputation and Carboplatin Chemotherapy: A Multi-Institutional Study.
    London CA; Gardner HL; Mathie T; Stingle N; Portela R; Pennell ML; Clifford CA; Rosenberg MP; Vail DM; Williams LE; Cronin KL; Wilson-Robles H; Borgatti A; Henry CJ; Bailey DB; Locke J; Northrup NC; Crawford-Jakubiak M; Gill VL; Klein MK; Ruslander DM; Thamm DH; Phillips B; Post G
    PLoS One; 2015; 10(4):e0124889. PubMed ID: 25923466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.